BioCryst Pharmaceuticals, Inc. (BMV:BCRX)
Mexico flag Mexico · Delayed Price · Currency is MXN
197.50
0.00 (0.00%)
At close: May 23, 2025

BioCryst Pharmaceuticals Ratios and Metrics

Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
44,23432,45720,74041,74651,09026,175
Upgrade
Market Cap Growth
84.58%56.49%-50.32%-18.29%95.19%161.10%
Upgrade
Enterprise Value
54,46243,12828,31147,49953,36624,930
Upgrade
Last Close Price
197.50155.00113.92215.00255.00148.00
Upgrade
PS Ratio
4.303.463.707.9015.8673.85
Upgrade
PB Ratio
-4.79-3.27-2.69-7.26-23.29-68.29
Upgrade
EV/Sales Ratio
5.654.595.058.9916.5670.34
Upgrade
EV/EBITDA Ratio
71.591194.32----
Upgrade
Debt / Equity Ratio
-1.83-1.77-1.86-2.52-5.54-14.51
Upgrade
Debt / EBITDA Ratio
20.87208.58----
Upgrade
Asset Turnover
1.060.900.620.480.340.07
Upgrade
Inventory Turnover
9.8210.117.7112.0018.93-
Upgrade
Quick Ratio
2.782.492.974.505.182.93
Upgrade
Current Ratio
2.932.633.314.895.463.07
Upgrade
Return on Equity (ROE)
------1925.37%
Upgrade
Return on Assets (ROA)
4.54%-0.16%-11.57%-16.30%-24.07%-41.60%
Upgrade
Return on Capital (ROIC)
5.71%-0.21%-14.70%-19.88%-29.76%-55.37%
Upgrade
Earnings Yield
-2.47%-5.71%-18.47%-11.55%-7.39%-13.90%
Upgrade
FCF Yield
-1.24%-3.41%-7.93%-7.63%-5.80%-10.31%
Upgrade
Buyback Yield / Dilution
-5.50%-7.54%-3.38%-3.79%-7.08%-44.70%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.